MSMatthias Sturzenegger

Matthias Sturzenegger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Matthias Sturzenegger has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Christian W. Hess

    University Hospital, Inselspital

    2 shared publications
  • Gerhard Schroth

    From the Departments of Neurology (K.N., T.J.L., F.S., M.A., H.P.M., M.S.) and Neuroradiology (G.S.), University Hospital of Bern, Inselspital, Bern, Switzerland

    2 shared publications
  • A Nirkko

    Department of Neurology, University Hospital of Bern, Bern, Switzerland

    1 shared publication
  • Alexander Schnabel

    1 shared publication
  • Andreas Baumann

    Dept. of Neurology, University of Bern, University Hospital, Inselspital, Freiburgstrasse, 3010, Bern, Switzerland

    1 shared publication
  • Andreas F. Hottinger

    Department of Neurology, University Hospital of Bern, Inselspital, Freiburgstrasse 30, CH‐3010 Bern, Switzerland

    1 shared publication

Latest Publications

  • Open Access

    Awareness of headache and of national headache society activities among primary care physicians – a qualitative study

    by Andreas R Gantenbein, Christian Jäggi, Mathias Sturzenegger, Claudio Gobbi, Gabriele S Merki-Feld, Mark J Emmenegger, Ethan Taub, Peter S Sándor

    Headache is one of the most common symptoms in primary care. To improve the quality of headache diagnosis and management with the largest possible benefit for the general population, headache and pain societies around the world have recently been devoting more attention to headache in primary care.


  • Headache Due to Dissection

    by Mathias Sturzenegger

  • Open Access

    Response to Letter by Metso et al

    by Krassen Nedeltchev, Stefan Bickel, Marcel Arnold, Hakan Sarikaya, Dimitrios Georgiadis, Matthias Sturzenegger, Heinrich P. Mattle, Ralf W. Baumgartner, Antti Metso, Tiina Metso, et al.

  • IVIg dose increase in multifocal motor neuropathy

    by Andreas Baumann, Christian W. Hess, Matthias Sturzenegger

    In this prospective, non-randomized 6-month observational study we evaluated the efficacy of intravenous immunoglobulin (IVIg) dose increase in patients with multifocal motor neuropathy (MMN). Diagnosis according to AAEM criteria, repetitive IVIg treatment for at least one year, persistent paresis and conduction block, stable symptoms and findings for at least six months were inclusion criteria. Nine patients (7 men) were identified and approved to standardized increase of IVIg dose. Patients were monitored using clinical scores and electrophysiological studies. Dose was increased from a baseline of 0.5 g/kg per month [mean, range: 0.1–1.1], given at variable intervals [4–12 weeks] to 1.2 g/kg per month given over 3 consecutive days planned for 6 cycles. If the patients’ motor function did not improve after two cycles they entered step two: Dose was increased to 2 g/kg per month given over 5 consecutive days. The increased dose was maintained for 6 months. Assessments were performed by the same investigator, not involved in the patient’s management, at baseline, after 2 and after 6 months. Following dose increase, motor function significantly improved in 6 patients (p = 0.014), 2 patients entered step two, 1 patient withdrew due to absent efficacy. Higher doses of IVIg caused more side effects, however, transient and rarely severe (p = 0.014). IVIg dose increase may improve motor functions in patients with stable MMN on long-term IVIg therapy independent of baseline dose. Improvement of motor function was associated with shorter disease duration (p = 0.008), but not with degree of muscle atrophy (p = 0.483). The treatment strategy to try to find the lowest effective dose and the longest tolerated interval might lead to underdosing in the long-term in many patients.


  • Symptomatic epilepsy with a tumor in the nose

    by Lars Eichler, Werner J. Z’gRaggen, Marco Caversaccio, Matthias Sturzenegger


  • Combined femoral and obturator neuropathy caused by synovial cyst of the hip

    by Moritz Stuplich, Andreas F. Hottinger, Christoforos Stoupis, Mathias Sturzenegger

    A 57‐year‐old man with a history of severe degenerative lumbar spine disease presented with painful proximal weakness of the right leg. Clinical examination suggested a femoral and obturator neuropathy with a palpable mass in the right groin. Magnetic resonance (MR) imaging disclosed a large synovial cyst of the underlying hip joint in the extrapelvic part of the iliopsoas and external obturator muscles, with femoral and obturator nerve compression. This case highlights the importance of detailed clinical examination in patients with multiple joint disease, the need for considering space‐occupying cysts of degenerated joints as a potential cause of nerve damage in unusual locations, and the value of multiplanar MR imaging for proper diagnosis in such situations. Muscle Nerve, 2005


  • Cerebrovascular Response to Repetitive Visual Stimulation in Interictal Migraine with Aura

    by K Nedeltchev, M Arnold, M Schwerzmann, A Nirkko, F Lagger, Hp Mattle, M Sturzenegger

    Cortical hypersensitivity and absent habituation to different stimuli have been observed in migraine patients. These features might also be transmitted to the cerebral vasoreactivity, but results are conflicting so far. Transcranial Doppler ultrasound (TCD) was used to assess cerebral blood flow velocity (CBFV) changes in the middle (MCA) and posterior cerebral arteries (PCA) in relation to repetitive checkerboard visual stimulation. Stimulation consisted of 10 consecutive cycles, each comprising 10 s stimulation and 10 s rest. TCD recordings were analysed using stimulus-related averaging algorithm. Data of 19 interictal migraineurs with aura were compared to those of 19 headache-free healthy volunteers. The CBFV increase in PCA and in MCA during visual stimulation was significantly larger and steeper in migraineurs than in controls (P = 0.017 and P = 0.005). The response in PCA remained stable over the 10 stimulation cycles, both in migraineurs and in controls. The response in MCA was stable only in migraineurs. In controls it decreased over the last 5 stimulation cycles compared with the first 5 cycles (P = 0.04). Migraineurs with aura exhibit a larger cerebrovascular response to repetitive visual stimulation compared to headache-free subjects. A reduced adaptation to environmental stimuli in migraine is suggested, since there was no habituation in migraineurs in contrast to healthy controls.


  • Long-Term Outcome of Acute Spinal Cord Ischemia Syndrome

    by Krassen Nedeltchev, Thomas J. Loher, Frank Stepper, Marcel Arnold, Gerhard Schroth, Heinrich P. Mattle, Matthias Sturzenegger

    Background and Purpose— Current knowledge of long-term outcome in patients with acute spinal cord ischemia syndrome (ASCIS) is based on few studies with small sample sizes and Methods— From January 1990 through October 2002, 57 patients with ASCIS were admitted to our center. Follow-up data were available for 54. Neurological syndrome and initial degree of impairment were defined according to American Spinal Injury Association (ASIA)/International Medical Society of Paraplegia criteria. Functional outcome was assessed by walking ability and bladder control. Results— Mean age was 59.4 years; 29 were women; and mean follow-up was 4.5 years. The origin was atherosclerosis in 33.3%, aortic pathology in 15.8%, degenerative spine disease in 15.8%, cardiac embolism in 3.5%, systemic hypotension in 1.8%, epidural anesthesia in 1.8%, and cryptogenic in 28%. The initial motor deficit was severe in 30% (ASIA grades A and B), moderate in 28% (ASIA C), and mild in 42% (ASIA D). At follow-up, 41% had regained full walking ability, 30% were able to walk with aids, 20% were wheelchair bound, and 9% had died. Severe initial impairment (ASIA A and B) and female sex were independent predictors of unfavorable outcome ( P =0.012 and P =0.043). Conclusions— Considering a broad spectrum of clinical presentations and origins, the outcome in our study was more favorable than in previous studies reporting on ASCIS subgroups with more severe initial deficits.


  • Extensive white-matter changes in case of adult polyglucosan body disease

    by M. Berkhoff, J. Weis, G. Schroth, M. Sturzenegger

    Extensive white matter signal changes were observed on T2-weighted images of a 49-year-old man. He presented with a slowly progressive gait disorder, and finally developed severe dementia. Extensive metabolic and infectious investigations failed to disclose the underlying cause during life. Autopsy revealed adult polyglucosan body disease. We discuss MRI findings likely to permit this diagnosis if combined with clinical findings and nerve or skin biopsy.